BIO-REFERENCE LABS INC-NEW-
BRLI
BRLI was delisted on the 19th of August, 2015.
168 hedge funds and large institutions have $760M invested in BIO-REFERENCE LABS INC-NEW- in 2014 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 51 increasing their positions, 62 reducing their positions, and 19 closing their positions.
32% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 19
7% more capital invested
Capital invested by funds: $708M → $760M (+$52.2M)
4% more funds holding
Funds holding: 162 → 168 (+6)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
18% less repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 62
38% less call options, than puts
Call options by funds: $5.54M | Put options by funds: $8.94M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$15M |
| 2 |
Norges Bank
Oslo,
Norway
|
+$8.19M |
| 3 |
Neuberger Berman Group
New York
|
+$6.45M |
| 4 |
MRM
Michael R. Murphy
|
+$4.55M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.22M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$25.6M |
| 2 |
PIM
Perkins Investment Management
Chicago,
Illinois
|
-$13.3M |
| 3 |
MNA
Manning & Napier Advisors
Fairport,
New York
|
-$12.4M |
| 4 |
RP
Riverbridge Partners
Minneapolis,
Minnesota
|
-$10.7M |
| 5 |
AIM
Assured Investment Management
New York
|
-$9.33M |
BRLI Hedge Fund Activity: Q2 2014 in Review
168 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in BIO-REFERENCE LABS INC-NEW- (BRLI) for Q2 2014, worth a combined $760M — up 7.4% from $708M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new BRLI positions and 19 closed out — a net gain of 6 holders — while 51 added to existing stakes and 62 trimmed.
The largest buyer was Camber Capital Management, opening a new position worth an estimated $15M. The largest seller was Manulife (Manufacturers Life Insurance), cutting an estimated $25.6M.
- 168 institutional investors held BIO-REFERENCE LABS INC-NEW- (BRLI) as of Q2 2014, up from 162 in Q1 2014.
- Funds reported $760M of BIO-REFERENCE LABS INC-NEW- stock for Q2 2014, up 7.4% quarter-over-quarter.
- 25 funds opened new BIO-REFERENCE LABS INC-NEW- positions in Q2 2014 and 19 closed out, a net change of +6 holders.
- The largest BIO-REFERENCE LABS INC-NEW- buyer in Q2 2014 was Camber Capital Management, an estimated $15M added.
- The largest BIO-REFERENCE LABS INC-NEW- seller in Q2 2014 was Manulife (Manufacturers Life Insurance), an estimated $25.6M sold.
Based on aggregated 13F filings for Q2 2014.